Study to Assess Adverse Events and Change in Disease Activity of Oral Cariprazine Capsules in Adult Participants With Schizophrenia
Clinical trial NCT05368558 · TERMINATED
Trial details
- NCT number
- NCT05368558
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-18
- Primary completion
- 2024-09-20
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.